InVivo appoints Perrin as new CEO

InVivo Therapeutics announced the appointment of Mark Perrin as CEO, effective Jan. 6.

Company news: Edelman, Pfizer, Publicis, Lippincott

Healthcare PR giant Dan Edelman dies; Pfizer says 'no comment' on breakup speculation; Publicis Healthcare snags a new SVP; Lippincott gives nurses a new drug diagnosis tool.

Company news: FDA, Shire, Bayer

A third-party review says FDA employees need more support; Shire launches rare disease research; and Bayer drops Schiff bid

Company news: Merck, Novo Nordisk

Merck slims down, Novo goes wide

What's more important to pharma execs? A large paycheck or a great place to work?

MM&M's 26th annual Career & Salary Survey is now open. Help us to give you the truest picture of salaries, opportunities, migration, aspirations and opinions within pharma and healthcare marketing.

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.